Insider trading

Period: 120 months Stock: DXCM + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

605 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

605 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

605 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

605 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
605 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
605 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

605 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Jul 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$100.72K 1,450 at 69.47
1.3%
12 Jul 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$431.17K 6,000 at 71.86
1.8%
10 Jul 2017
Balo Andrew K EVP, Reg. Strategy, Clinical
Sold, plan not stated
$228.97K 3,200 at 71.55
3.0%
23 Jun 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$249.27K 3,187 at 78.22
11.1%
23 Jun 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$113.38K 1,450 at 78.19
1.3%
12 Jun 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$414.41K 6,000 at 69.07
1.8%
12 Jun 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated
$220.99K 3,200 at 69.06
2.9%
23 May 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$217.29K 3,182 at 68.29
10.0%
23 May 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$98.95K 1,450 at 68.24
1.2%
17 May 2017
SAYER KEVIN R President & CEO
Sold, plan not stated 2×
$591.52K 8,649 at 68.39
2.5%
10 May 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated
$230.18K 3,200 at 71.93
2.8%
24 Apr 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$241.13K 3,182 at 75.78
33.3%
24 Apr 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$110.04K 1,450 at 75.89
1.2%
20 Apr 2017
GREGG TERRANCE H Executive Chairman · indirect
Sold, plan not stated
$1.11M 15,000 at 74.10
26.8%
17 Apr 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$756.32K 10,000 at 75.63
2.8%
10 Apr 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated
$250.21K 3,200 at 78.19
2.8%
23 Mar 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$304.01K 3,987 at 76.25
3.2%
23 Mar 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$243.03K 3,182 at 76.38
25.0%
22 Mar 2017
ROPER JESS SVP, CFO · indirect
Sold, plan not stated
$151.94K 2,000 at 75.97
19.1%
17 Mar 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$778.16K 10,000 at 77.82
2.8%
14 Mar 2017
Leach Jacob Steven SVP, Research & Development
Sold, plan not stated
$235.82K 3,050 at 77.32
3.6%
14 Mar 2017
KAHN BARBARA Director · indirect
Sold, plan not stated
$232.08K 3,000 at 77.36
12.3%
13 Mar 2017
VALDES JORGE A CTO · indirect
Sold, plan not stated
$1.12M 14,400 at 77.74
58.0%
Sold half or more
13 Mar 2017
Leach Jacob Steven SVP, Research & Development
Sold, plan not stated 2×
$617.99K 7,926 at 77.97
8.5%
10 Mar 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated
$248.67K 3,200 at 77.71
2.4%
9 Mar 2017
Leach Jacob Steven SVP, Research & Development
Sold, plan not stated 2×
$801.07K 10,341 at 77.47
9.8%
9 Mar 2017
LISTER JOHN General Manager, EMEA
Sold, plan not stated
$233.00K 3,000 at 77.67
3.1%
6 Mar 2017
SKYLER JAY S Director · indirect
Sold, plan not stated
$2.49M 31,890 at 78.13
64.9%
Sold half or more
23 Feb 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$249.53K 3,182 at 78.42
20.0%
22 Feb 2017
ROPER JESS SVP, CFO · indirect
Sold, plan not stated
$183.76K 2,333 at 78.76
18.2%
17 Feb 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$816.18K 10,000 at 81.62
3.2%
10 Feb 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated 2×
$253.76K 3,200 at 79.30
3.0%
9 Feb 2017
Sold, plan not stated
$558.32K 7,000 at 79.76
8.8%
9 Feb 2017
LISTER JOHN General Manager, EMEA
Sold, plan not stated
$239.20K 3,000 at 79.73
4.1%
1 Feb 2017
Sold, plan not stated
$1.11M 13,900 at 80.00
16.1%
23 Jan 2017
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$770.91K 9,637 at 79.99
8.0%
23 Jan 2017
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$252.98K 3,182 at 79.50
16.7%
18 Jan 2017
ROPER JESS SVP, CFO · indirect
Sold, plan not stated
$256.05K 3,012 at 85.01
19.1%
17 Jan 2017
SAYER KEVIN R President & CEO
Sold, plan not stated
$859.36K 10,000 at 85.94
3.2%
13 Jan 2017
Sold, plan not stated 3×
$2.09M 26,100 at 80.00
26.5%
13 Jan 2017
LISTER JOHN General Manager, EMEA
Sold, plan not stated
$1.19M 15,000 at 79.36
17.5%
10 Jan 2017
Balo Andrew K EVP, Clinical and Regulatory
Sold, plan not stated
$201.15K 3,200 at 62.86
2.9%
9 Jan 2017
Sold, plan not stated 4×
$686.90K 10,900 at 63.02
13.1%
9 Jan 2017
LISTER JOHN General Manager, EMEA
Sold, plan not stated
$189.05K 3,000 at 63.02
4.1%
23 Dec 2016
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$197.83K 3,182 at 62.17
14.3%
14 Dec 2016
ROPER JESS SVP, CFO · indirect
Sold, plan not stated
$156.62K 2,442 at 64.14
13.4%
9 Dec 2016
Sold, plan not stated 3×
$648.08K 10,000 at 64.81
12.1%
23 Nov 2016
Pacelli Steven Robert EVP, Strategy & Corp. Dev.
Sold, plan not stated
$724.26K 10,300 at 70.32
8.5%
23 Nov 2016
DOUBLEDAY RICHARD EVP, Chief Commercial Officer · indirect
Sold, plan not stated
$223.35K 3,182 at 70.19
12.5%
9 Nov 2016
LISTER JOHN General Manager, EMEA
Sold, plan not stated
$213.56K 3,417 at 62.50
4.6%
Showing 551–600 of 605. ← Newer Page 12 of 13 Older →